ES2292620T3 - Empleo de acido 13-cis retionico para el tratamiento de enfisema. - Google Patents

Empleo de acido 13-cis retionico para el tratamiento de enfisema. Download PDF

Info

Publication number
ES2292620T3
ES2292620T3 ES01969477T ES01969477T ES2292620T3 ES 2292620 T3 ES2292620 T3 ES 2292620T3 ES 01969477 T ES01969477 T ES 01969477T ES 01969477 T ES01969477 T ES 01969477T ES 2292620 T3 ES2292620 T3 ES 2292620T3
Authority
ES
Spain
Prior art keywords
cis
retinoic acid
emphysema
pharmaceutically acceptable
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01969477T
Other languages
English (en)
Spanish (es)
Inventor
Paula Nanette Belloni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2292620T3 publication Critical patent/ES2292620T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES01969477T 2000-08-02 2001-07-23 Empleo de acido 13-cis retionico para el tratamiento de enfisema. Expired - Lifetime ES2292620T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/631,151 US6339107B1 (en) 2000-08-02 2000-08-02 Methods for treatment of Emphysema using 13-cis retinoic acid
US631151 2000-08-02

Publications (1)

Publication Number Publication Date
ES2292620T3 true ES2292620T3 (es) 2008-03-16

Family

ID=24529991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01969477T Expired - Lifetime ES2292620T3 (es) 2000-08-02 2001-07-23 Empleo de acido 13-cis retionico para el tratamiento de enfisema.

Country Status (7)

Country Link
US (2) US6339107B1 (enExample)
EP (1) EP1307187B1 (enExample)
JP (1) JP2004505036A (enExample)
AU (1) AU2001289726A1 (enExample)
DE (1) DE60130661T2 (enExample)
ES (1) ES2292620T3 (enExample)
WO (1) WO2002009679A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
EP1370238B1 (en) * 2001-03-22 2008-11-12 Battelle Memorial Institute Liquid formulations for electrohydrodynamic spraying containing polymer and suspended particles
KR20050042013A (ko) * 2001-10-30 2005-05-04 넥타르 테라퓨틱스 에이엘, 코포레이션 레티노산의 수용성 중합체 콘쥬게이트
US20030185762A1 (en) * 2002-03-22 2003-10-02 Cowan Siu Man L. Highly aqueous liquid carrier formulations
WO2004022042A1 (en) * 2002-09-06 2004-03-18 Oregon Health And Science University Effect of vitamin a gel on paranasal sinus mucosal regeneration
WO2006025395A1 (ja) * 2004-08-31 2006-03-09 Yasuhiko Shimizu キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
WO2006079209A1 (en) * 2005-01-26 2006-08-03 The University Of British Columbia Pulmonary compositions comprising a vitamin a compound and a surfactant and uses thereof
US20080027031A1 (en) * 2006-03-08 2008-01-31 Kinemed, Inc. Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
CA2762391C (en) * 2009-05-20 2017-02-07 Ranbaxy Laboratories Limited Liquid dosage forms of isotretinoin
SG176097A1 (en) 2009-05-20 2011-12-29 Ranbaxy Lab Ltd Topical retinoid solutions
HK1216843A1 (zh) * 2012-12-27 2016-12-09 Microdose Therapeutx, Inc. 用於施用奥昔布宁的方法和组合物
JP6826731B2 (ja) * 2015-09-10 2021-02-10 国立大学法人 岡山大学 炎症性呼吸器疾患の予防又は治療用医薬組成物
CN113372368B (zh) 2020-03-09 2022-04-12 苏州爱科百发生物医药技术有限公司 一种弹性蛋白酶抑制剂前药及其用途
CN118900688A (zh) * 2022-03-08 2024-11-05 至善生医股份有限公司 包括视黄酸及碳水化合物的医药组合物及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB334585A (en) * 1929-06-06 1930-09-08 British Glues And Chemicals Lt Improvements in or relating to the separation of solids from liquids
ZA791659B (en) 1978-04-17 1980-04-30 Ici Ltd Process and apparatus for spraying liquid
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
IL90069A (en) 1988-04-26 1994-04-12 Us Health The use of 31 cysts of retinoic acid in the preparation of a drug for the treatment of congenital conjunctivitis
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
TW272187B (enExample) 1992-05-20 1996-03-11 Hoffmann La Roche
GB9225098D0 (en) 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
GB9226717D0 (en) 1992-12-22 1993-02-17 Coffee Ronald A Induction-operated electro-hydrodynamic spray device with means of modifying droplet trajectories
GB9406171D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9406255D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9410658D0 (en) 1994-05-27 1994-07-13 Electrosols Ltd Dispensing device
ZA962078B (en) 1995-03-14 1996-09-25 Siemens Ag Ultrasonic atomizer device with removable precision dosating unit
WO1996028205A1 (en) 1995-03-14 1996-09-19 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
WO1997039745A1 (en) 1996-04-19 1997-10-30 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
US6515022B2 (en) * 1996-04-19 2003-02-04 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the treatment of lung diseases
US5998486A (en) 1997-07-08 1999-12-07 Georgetown University School Of Medicine Treatment of emphysema with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli)
NZ504021A (en) 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
NZ506289A (en) 1998-03-16 2004-12-24 Nektar Therapeutics Aerosolized active agent delivery to the lungs at a flow rate of less than 17 liters per minute
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid

Also Published As

Publication number Publication date
DE60130661T2 (de) 2008-07-03
US20020049252A1 (en) 2002-04-25
JP2004505036A (ja) 2004-02-19
US6339107B1 (en) 2002-01-15
EP1307187A2 (en) 2003-05-07
AU2001289726A1 (en) 2002-02-13
US6794416B2 (en) 2004-09-21
WO2002009679A2 (en) 2002-02-07
DE60130661D1 (de) 2007-11-08
EP1307187B1 (en) 2007-09-26
WO2002009679A3 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
ES2292620T3 (es) Empleo de acido 13-cis retionico para el tratamiento de enfisema.
ES2779273T3 (es) Formulación superfina de formoterol
ES2762806T3 (es) Tratamiento utilizando estabilizadores de mastocitos para trastornos sistémicos
ES2222294T3 (es) Formulacion optimizada de tobramicina para administracion en forma de aerosol.
Clarke et al. Therapeutic aerosols 2--Drugs available by the inhaled route
JP2003519664A (ja) Ｇｌｐ−１誘導体の経上皮送達
CA3035528A1 (en) Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
US20030114384A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
US20240197770A1 (en) Compositions and methods for treating elastic fiber breakdown
US6300350B1 (en) Treatment of emphysema using RARy selective retinoid agonists
US20220409627A1 (en) Treatment of lower airways disorders
US20220339099A1 (en) Compositions of interleukin-1 receptor antagonist
TW200922600A (en) DHEAS inhalation compositions
ES2471139T3 (es) Combinaciones ventajosas para la inhalaci�n de nacistelina y broncodilatadores
CN113577059B (zh) 一种用于小儿哮喘的活性药物
CN116196298A (zh) 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
Li et al. Respiratory Drugs
CA2602007A1 (en) Particle and preparation containing the particle
US20120295982A1 (en) Treating human male copd patients with oral bedoradrine
WO2003037309A2 (en) USE OF 4α PHORBOL